Investors / China / Gaorong Capital
Gaorong Capital
Venture capital · George Town, China · Asia Pacific
Gaorong Capital is an investment firm based in China. Its website provides contact details for business plans and lists portfolio and team information.
Your fit with Gaorong Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsGaorong Capital lists 12 checked portfolio companies on its own site and is named in 18 funding rounds, 3 of them as lead. Its most frequent entry is Series A, 29% of the companies with a known first round. Its largest themes are Healthcare & Biotech (50%), AI & Machine Learning (19%) and Robotics & Hardware (6%). 50% of its companies are based in China. It invests most often alongside Monolith Management, 3E Bioventures Capital and ARCH Venture Partners.
Counts come from funding rounds that name Gaorong Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundGaorong Capital does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 18% |
| Series A | 29% |
| Series B | 29% |
| Growth | 24% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 1 | 0 |
| '25 | 5 | 1 |
| '26 | 12 | 2 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 30th | 12 companies |
| Recent activity | 97th | 13 rounds in 12 months |
| Early stage | 57th | 18% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 85th | 50% in its largest sector |
| Reach | 58th | 3 countries |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 50% | 15% |
| AI & Machine Learning | 19% | 18% |
| Robotics & Hardware | 6% | 1% |
| Industrial & Manufacturing | 6% | 7% |
| Media & Entertainment | 6% | 4% |
| Fintech | 6% | 12% |
| E-commerce & Marketplaces | 6% | 6% |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers12100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Monolith Management | 2 |
| 3E Bioventures Capital | 1 |
| ARCH Venture Partners | 1 |
| Alpha JWC Ventures | 1 |
| Alphawave Group | 1 |
| Alumni Ventures | 1 |
| Amino Capital | 1 |
| Archerman Capital | 1 |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Monolith Management
Compare Gaorong Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Gaorong Capital| Date | Company | Stage |
|---|---|---|
| 3 Nov 2026 | Series C+ Led | |
| 8 Sept 2026 | Series B | |
| 30 Jul 2026 | Series A | |
| 9 Jun 2026 | Series B | |
| 29 Apr 2026 | Series A | |
| 16 Mar 2026 | Series B | |
| 11 Feb 2026 | Series A Led | |
| 1 Dec 2025 | Seed Led |
Round details for Gaorong Capital
Amounts, full round histories and every co-investor in Gaorong Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
12 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Arnatar Therapeutics develops RNA medicines to treat various diseases, including cardiometabolic, liver, CNS, and kidney diseases. | Healthcare & Biotech | Aug 2025Series A | Funding round | |
| Axoft develops bioinspired implants that mimic the soft tissues of the brain to provide long-term communication with any brain region at single-neuron resolution. | Healthcare & Biotech | Apr 2026Series A | Funding round | |
| BioGeometry develops and applies generative AI models for protein design and biologics development | Healthcare & Biotech | Jun 2026Series B | Funding round | |
| The company makes delicate and complex minimally invasive surgical procedures easier for surgeons, delivering favourable patient outcomes. | Healthcare & Biotech | Nov 2025Round | Funding round | |
| The company develops innovative drugs for central nervous system and eye diseases | Healthcare & Biotech | Jul 2026Series A | Funding round | |
| The company develops and promotes flying cars and offers flying experiences | AI & Machine Learning | Mar 2026Series B | Funding round | |
| The company provides a VR platform for teaching Western anatomy and Chinese medicine | Healthcare & Biotech | Oct 2025Seed | Funding round | |
| Moonwalk Biosciences is developing first-in-class, adipose-targeted RNA therapies that address the biology of cardiometabolic diseases | Healthcare & Biotech | Sept 2026Series B | Funding round | |
| Nanochap Electronics Co., Ltd develops and manufactures brain-computer interfaces and biochips, including products for restoring vision and neural stimulation. | Healthcare & BiotechRobotics & Hardware | Nov 2026Series C+ | Funding round | |
| The company develops and manufactures autonomous vehicles for logistics and transportation. | Industrial & ManufacturingAI & Machine Learning | Oct 2025Series C+ | Funding round | |
| Pollo AI provides a suite of AI tools to transform text and images into videos and edit photos. | AI & Machine LearningMedia & Entertainment | Dec 2025Seed | Funding round | |
| Waffo provides global payments and monetization services, including payment processing and revenue management | FintechE-commerce & Marketplaces | Feb 2026Series A | Funding round |
About this data
site last read 12 Nov 2026- Site
- gaorongvc.com
- Last read
- 12 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 28 Nov 2024
- Companies checked
- 12
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Gaorong Capital's profile as data
Pull Gaorong Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/gaorongvc.com
# also
GET /v1/firms/gaorongvc.com/portfolio
GET /v1/firms/gaorongvc.com/coinvestors
GET /v1/firms/gaorongvc.com/news